Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302)
Phase 3
Completed
- Conditions
- Hypertension
- Registration Number
- NCT00092209
- Lead Sponsor
- Organon and Co
- Brief Summary
The purpose of this study is to evaluate antihypertensive (lowering blood pressure) effectiveness of three combinations of approved study drugs compared to both study drugs being given alone.
- Detailed Description
The duration of treatment is 3.5 months.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 840
Inclusion Criteria
- Japanese ancestry
- Stable high blood pressure defined by the study criteria
Exclusion Criteria
- Pregnant or nursing
- Significant concurrent kidney, liver, blood, or other disease
- Recent heart attack or heart surgery
- History of stroke, severe hypertension (high blood pressure), significant heart failure or cardiac arrhythmias
- Significant lab abnormalities
- Uncontrolled blood sugar
- History of certain drug allergies
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Mean trough SiDBP after 8 weeks of treatment
- Secondary Outcome Measures
Name Time Method Safety